Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel, oxaliplatin, and S-1 in advanced gastric cancer
NCT05052931Phase 2Unknown
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in gastric adenocarcinoma. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT05052931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05052931.